Abstract: The present invention provides compounds of formula (I): or a pharmaceutically acceptable salt or a stereoisomer thereof; wherein, R1, R2, R3, R4, R5, R6, m and n have the meanings given in the specification. The compounds of the present disclosure are useful for staining cells particularly as green fluorescent mitochondrial stain. The compound may be used for staining on all the cell types using simple direct staining protocols. The compound may be compatible in all three environments that is in vitro, in vivo and ex vivo.
DESC:Please refer the attached Complete Specification ,CLAIMS:Please refer the attached Complete Specification
| # | Name | Date |
|---|---|---|
| 1 | 202041020018-STATEMENT OF UNDERTAKING (FORM 3) [12-05-2020(online)].pdf | 2020-05-12 |
| 2 | 202041020018-PROVISIONAL SPECIFICATION [12-05-2020(online)].pdf | 2020-05-12 |
| 3 | 202041020018-POWER OF AUTHORITY [12-05-2020(online)].pdf | 2020-05-12 |
| 4 | 202041020018-FORM 1 [12-05-2020(online)].pdf | 2020-05-12 |
| 5 | 202041020018-DRAWINGS [12-05-2020(online)].pdf | 2020-05-12 |
| 6 | 202041020018-DECLARATION OF INVENTORSHIP (FORM 5) [12-05-2020(online)].pdf | 2020-05-12 |
| 7 | 202041020018-RELEVANT DOCUMENTS [19-05-2020(online)].pdf | 2020-05-19 |
| 8 | 202041020018-FORM 13 [19-05-2020(online)].pdf | 2020-05-19 |
| 9 | 202041020018-Proof of Right [27-10-2020(online)].pdf | 2020-10-27 |
| 10 | 202041020018-DRAWING [12-05-2021(online)].pdf | 2021-05-12 |
| 11 | 202041020018-CORRESPONDENCE-OTHERS [12-05-2021(online)].pdf | 2021-05-12 |
| 12 | 202041020018-COMPLETE SPECIFICATION [12-05-2021(online)].pdf | 2021-05-12 |
| 13 | 202041020018-FORM 18A [31-10-2022(online)].pdf | 2022-10-31 |
| 14 | 202041020018-EVIDENCE OF ELIGIBILTY RULE 24C1h [31-10-2022(online)].pdf | 2022-10-31 |
| 15 | 202041020018-EVIDENCE FOR REGISTRATION UNDER SSI [31-10-2022(online)].pdf | 2022-10-31 |
| 16 | 202041020018-EDUCATIONAL INSTITUTION(S) [31-10-2022(online)].pdf | 2022-10-31 |
| 17 | 202041020018-FER.pdf | 2023-01-03 |
| 18 | 202041020018-OTHERS [12-04-2023(online)].pdf | 2023-04-12 |
| 19 | 202041020018-FER_SER_REPLY [12-04-2023(online)].pdf | 2023-04-12 |
| 20 | 202041020018-COMPLETE SPECIFICATION [12-04-2023(online)].pdf | 2023-04-12 |
| 21 | 202041020018-CLAIMS [12-04-2023(online)].pdf | 2023-04-12 |
| 22 | 202041020018-US(14)-HearingNotice-(HearingDate-12-06-2023).pdf | 2023-05-09 |
| 23 | 202041020018-FORM-26 [08-06-2023(online)].pdf | 2023-06-08 |
| 24 | 202041020018-Correspondence to notify the Controller [08-06-2023(online)].pdf | 2023-06-08 |
| 25 | 202041020018-Written submissions and relevant documents [23-06-2023(online)].pdf | 2023-06-23 |
| 26 | 202041020018-FORM-8 [14-07-2023(online)].pdf | 2023-07-14 |
| 27 | 202041020018-PatentCertificate04-01-2024.pdf | 2024-01-04 |
| 28 | 202041020018-IntimationOfGrant04-01-2024.pdf | 2024-01-04 |
| 29 | 202041020018-Response to office action [19-09-2025(online)].pdf | 2025-09-19 |
| 1 | searchE_03-01-2023.pdf |
| 2 | 202041020018searchE_03-01-2023.pdf |